BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14530190)

  • 1. Association between apolipoprotein E alleles and calcific valvular heart disease.
    Novaro GM; Sachar R; Pearce GL; Sprecher DL; Griffin BP
    Circulation; 2003 Oct; 108(15):1804-8. PubMed ID: 14530190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels.
    Saidi S; Slamia LB; Ammou SB; Mahjoub T; Almawi WY
    J Stroke Cerebrovasc Dis; 2007; 16(4):160-6. PubMed ID: 17689412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E epsilon4 allele is associated with left ventricular systolic dysfunction.
    Bleumink GS; van Duijn CM; Kingma JH; Witteman JC; Hofman A; Stricker BH
    Am Heart J; 2004 Apr; 147(4):685-9. PubMed ID: 15077085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valvular calcification and its relationship to atherosclerosis in chronic kidney disease.
    Leskinen Y; Paana T; Saha H; Groundstroem K; Lehtimäki T; Kilpinen S; Huhtala H; Airaksinen J
    J Heart Valve Dis; 2009 Jul; 18(4):429-38. PubMed ID: 19852148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sectional association of kidney function with valvular and annular calcification: the Framingham heart study.
    Fox CS; Larson MG; Vasan RS; Guo CY; Parise H; Levy D; Leip EP; O'donnell CJ; D'Agostino RB; Benjamin EJ
    J Am Soc Nephrol; 2006 Feb; 17(2):521-7. PubMed ID: 16382018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
    Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
    Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E4 polymorphism as a genetic predisposition to delirium in critically ill patients.
    Ely EW; Girard TD; Shintani AK; Jackson JC; Gordon SM; Thomason JW; Pun BT; Canonico AE; Light RW; Pandharipande P; Laskowitz DT
    Crit Care Med; 2007 Jan; 35(1):112-7. PubMed ID: 17133176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid profile and apolipoprotein E polymorphism in essential hypertension.
    Bhavani AB; Sastry KB; Reddy NK; Padma T
    Indian Heart J; 2005; 57(2):151-7. PubMed ID: 16013355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E gene polymorphism and the risk of cervical myelopathy in patients with chronic spinal cord compression.
    Setzer M; Hermann E; Seifert V; Marquardt G
    Spine (Phila Pa 1976); 2008 Mar; 33(5):497-502. PubMed ID: 18317192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia.
    Pankratz N; Byder L; Halter C; Rudolph A; Shults CW; Conneally PM; Foroud T; Nichols WC
    Mov Disord; 2006 Jan; 21(1):45-9. PubMed ID: 16116614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Apolipoprotein E and angiotensin-converting enzyme gene polymorphisms as risk factors of coronary disease].
    Bennouar N; Allami A; Laraqui A; Azeddoug H; El-Kadiri N; Benkouka F; Bendriss A; Ghannam R; Benomar A; Fellat S; Benomar M
    Ann Biol Clin (Paris); 2004; 62(3):295-304. PubMed ID: 15217762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein e4 allele and the risk of CAD death in type 2 diabetes mellitus with ischaemia electrocardiographic change.
    Guang-da X; Xiang-Jiu Y; Lin-Shuang Z; Zhi-Song C; Yu-Sheng H
    Diabetes Res Clin Pract; 2005 Jun; 68(3):223-9. PubMed ID: 15936464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms of apolipoprotein E4 and tumor necrosis factor beta as predisposing factors for increased inflammatory cytokines after cardiopulmonary bypass.
    Grünenfelder J; Umbehr M; Plass A; Bestmann L; Maly FE; Zünd G; Turina M
    J Thorac Cardiovasc Surg; 2004 Jul; 128(1):92-7. PubMed ID: 15224026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of apoE polymorphism with lipoprotein(a), apoA, apoB and lipid levels in atherosclerotic infarct.
    Tascilar N; Dursun A; Ankarali H; Mungan G; Sumbuloglu V; Ekem S; Bozdogan S; Baris S; Aciman E; Cabuk F
    J Neurol Sci; 2009 Feb; 277(1-2):17-21. PubMed ID: 18945448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved prediction of early-onset coronary artery disease using APOE epsilon4, BChE-K, PPARgamma2 Pro12 and ENOS T-786C in a polygenic model.
    Nassar BA; Rockwood K; Kirkland SA; Ransom TP; Darvesh S; MacPherson K; Johnstone DE; O'Neill BJ; Bata IR; Andreou P; Jeffery JS; Cox JL; Title LM
    Clin Biochem; 2006 Feb; 39(2):109-14. PubMed ID: 16298355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E4 genotype is not associated with short-term cognition deficits during alcohol withdrawal.
    Wilhelm J; von Ahsen N; Frieling H; Hillemacher T; Bayerlein K; Bönsch D; Ziegenbein M; Kornhuber J; Bleich S
    Alcohol; 2005 Nov; 37(3):151-6. PubMed ID: 16713503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined effects of apoE-CI-CII cluster and LDL-R gene polymorphisms on chromosome 19 and coronary artery disease risk.
    Wang C; Zhou X; Ye S; Han D; Tan X; Zheng F; Shi Q
    Int J Hyg Environ Health; 2006 May; 209(3):265-73. PubMed ID: 16459141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E alleles and bicuspid aortic valve stenosis in monozygotic twins.
    Saravanan P; Kadir I
    Interact Cardiovasc Thorac Surg; 2009 Jun; 8(6):687-8. PubMed ID: 19304773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary atherosclerosis in patients with acquired valvular disease.
    Zapolski T; Wysokiński A; Przegaliński J; Wójcik J; Tomaszewski A; Drozd J; Madejczyk A; Pijanowski Z; Widomska-Czekajska T
    Kardiol Pol; 2004 Dec; 61(12):534-43; discussion 544-5. PubMed ID: 15815754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.